Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies - PubMed

Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies - PubMed

Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies

Stephanie R Keller 1, Eric J Mallack 2, Jennifer P Rubin 3, Jennifer A Accardo 4, Jennifer A Brault 5, Camille S Corre 6, Camila Elizondo 7, Jennifer Garafola 5, April C Jackson-Garcia 8, Jullie Rhee 9, Elisa Seeger 8, Kaprice C Shullanberger 8, Amanda Tourjee 6, Melissa K Trovato 10, Amy T Waldman 11, Jenna L Wallace 8, Michael R Wallace 8, Klaus Werner 12, Angela White 5, Kevin C Ess 5, Catherine Becker 6, Florian S Eichler 6

Affiliations 

• PMID: 32875938
 
• DOI: 10.1177/0883073820946154

Abstract

Leukodystrophies are a group of neurodegenerative genetic disorders that affect approximately 1 in 7500 individuals. Despite therapeutic progress in individual leukodystrophies, guidelines in neurologic care are sparse and consensus among physicians and caregivers remains a challenge. At patient advocacy meetings hosted by Hunter's Hope from 2016-2018, multidisciplinary experts and caregivers met to conduct a literature review, identify knowledge gaps and summarize best practices regarding neurologic care. Stages of severity in leukodystrophies guided recommendations to address different levels of need based on a newly defined system of disease severity. Four core neurologic domains prioritized by families were identified and became the focus of this guideline: sleep, pain, seizures/epilepsy, and language/cognition. Based on clinical severity, the following categories were used: presymptomatic, early symptomatic, intermediate symptomatic, and advanced symptomatic. Across the leukodystrophies, neurologic care should be tailored to stages of severity while accounting for unique aspects of every disease and multiple knowledge gaps present. Standardized tools and surveys can help guide treatment but should not overburden families.

Keywords: cognition; disability; genetics; leukodystrophy; pediatric; rehabilitation; seizures; sleep; spasticity.

Similar articles

• Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care Network.

  Page KM, Stenger EO, Connelly JA, Shyr D, West T, Wood S, Case L, Kester M, Shim S, Hammond L, Hammond M, Webb C, Biffi A, Bambach B, Fatemi A, Kurtzberg J.Biol Blood Marrow Transplant. 2019 Dec;25(12):e363-e374. doi: 10.1016/j.bbmt.2019.09.003. Epub 2019 Sep 6.PMID: 31499213 Review.
• An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.

  Ashrafi MR, Amanat M, Garshasbi M, Kameli R, Nilipour Y, Heidari M, Rezaei Z, Tavasoli AR.Expert Rev Neurother. 2020 Jan;20(1):65-84. doi: 10.1080/14737175.2020.1699060. Epub 2019 Dec 12.PMID: 31829048
• Leukodystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.

  Vanderver A, Tonduti D, Schiffmann R, Schmidt J, van der Knaap MS.2014 Feb 6. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.PMID: 24501781 Free Books & Documents. Review.
• The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

  Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.PMID: 31294385 Free PMC article.
• Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.

  MacKinnon K, Marcellus L, Rivers J, Gordon C, Ryan M, Butcher D.JBI Database System Rev Implement Rep. 2015 Jan;13(1):14-26. doi: 10.11124/jbisrir-2015-1694.PMID: 26447004